The bank closely resembles key features of the original tumors, such as ER/PR expression and mutational profiles (PIK3CA and TP53), offering an invaluable tool for investigating the molecular and cellular mechanisms that contribute to BC progression and drug resistance. Here, PGR is linked to breast cancer.